KALA BIO, Inc. (KALA) Stock Ticker
Market factors today
Unlock the full KALA picture
About KALA BIO, Inc.
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
KALA stock facts
| Ticker symbol | KALA |
| Exchange | NASDAQ Global Select |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $9.2M |
| CEO | Avi Minkowitz |
| Employees | 6 |
| Headquarters | Arlington, MA, US |
| IPO date | 2017-07-20 |
| Website | www.kalarx.com |
What you can see for KALA on Tickr
Live KALA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KALA report.
Rankings
FAQ
What is the ticker symbol for KALA BIO, Inc.?
The ticker symbol for KALA BIO, Inc. is KALA, listed on the NASDAQ Global Select.
What is KALA?
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by…